Dr. Parmis
Lead Medical Researcher
Leads GLP Review's provider scoring and clinical research. Focus areas: GLP-1/GIP receptor agonists, compounded peptides, 503A/503B pharmacy practice, and USP <797> sterile compounding.
About
An independent editorial publication.
GLP Review is published by Ranika Partners LLC. We score GLP-1 telehealth providers against a public rubric — and we don't sell our verdicts.
The team
Our research and review work is led by named people with verifiable credentials. Clinical review is advisory and firewalled from scoring.
Adam Kennah, M.D.
Medical Reviewer
Board-certified physician who reviews GLP Review's clinical content for accuracy. Reviews are advisory and do not influence ranking placement.
Julliana Edwards
Editor
Edits GLP Review for clarity, sourcing, and corrections. Maintains the public corrections log and oversees the editorial-independence firewall.
How we stay independent
Rankings are editorial and non-payable. No provider can pay for placement, a higher score, or favorable coverage. GLP Review is affiliate-supported; affiliate relationships never influence scores, which are determined solely by the published v3.0 six-pillar rubric.
Contact: editorial@glpreview.org · Publisher: Ranika Partners LLC